Acadian Asset Management
ONC

Acadian Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Acadian Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$170K Hold
597
– – ﹤0.01% 1667
2026
Q1 		$177K Buy
+597
New +$193K ﹤0.01% 1623
2025
Q4 		– Sell
-308
Closed -$104K – 2155
2025
Q3 		$104K Hold
308
– – ﹤0.01% 1515
2025
Q2 		$74K Sell
308
-2,077
-87% -$509K ﹤0.01% 1444
2025
Q1 		$649K Buy
+2,385
New +$558K ﹤0.01% 1024
2024
Q4 		– Sell
-34,140
Closed -$7.66M – 2247
2024
Q3 		$7.66M Buy
34,140
+33,193
+3,505% +$5.97M 0.02% 391
2024
Q2 		$135K Sell
947
-318
-25% -$49K ﹤0.01% 1495
2024
Q1 		$197K Buy
1,265
+849
+204% +$137K ﹤0.01% 1186
2023
Q4 		$75K Buy
+416
New +$75.3K ﹤0.01% 1404

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Acadian Asset Management's ONC Position: Q2 2026 in Review

Acadian Asset Management held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 597 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #1667.

Acadian Asset Management first reported a position in ONC in Q4 2023 and has held it in 9 quarters since. The position peaked at $7.66M in Q3 2024. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Acadian Asset Management held 597 shares of BeOne Medicines Ltd worth $170K as of Q2 2026.
  • Acadian Asset Management left its BeOne Medicines Ltd share count unchanged in Q2 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1667 holding.
  • Acadian Asset Management first reported a position in BeOne Medicines Ltd in Q4 2023 and has held it in 9 quarters since.
  • Acadian Asset Management's BeOne Medicines Ltd position peaked at $7.66M in Q3 2024.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.